| Date | Time | Source | Headline | Symbol | Company |
| 07/16/2015 | 5:13PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 07/16/2015 | 5:12PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 07/16/2015 | 5:09PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 07/16/2015 | 4:23PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 07/16/2015 | 9:10AM | PR Newswire (US) | Equity Coverage on Biotechnology -- Aeterna Zentaris, Ariad Pharma, AVEO Pharma, Aduro BioTech, and 22nd Century Group | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 07/14/2015 | 5:08PM | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 06/25/2015 | 4:08PM | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 06/17/2015 | 7:17PM | Business Wire | ARIAD rende noti i dati sulla sicurezza e l'efficacia a lungo termine di Ponatinib ottenuti da uno studio clinico Pace di fas... | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 06/16/2015 | 12:34PM | Business Wire | ARIAD met à jour les données de tolérance et d'efficacité à long terme du ponatinib,provenant de l'essai clinique de pha... | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 06/14/2015 | 8:53AM | Business Wire | ARIAD legt langfristige Sicherheits- und Wirksamkeitsdaten zu Ponatinib aus klinischer Phase-2-Studie PACE vor | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 06/12/2015 | 11:15AM | Business Wire | ARIAD Announces Long-Term Safety and Efficacy Data of Ponatinib from Phase 2 Pace Clinical Trial | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 06/10/2015 | 10:05AM | The Motley Fool | Cancer Stocks: 2 to Sell, 1 to Buy | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 06/10/2015 | 10:05AM | The Motley Fool | Cancer Stocks: 2 to Sell, 1 to Buy | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 06/10/2015 | 7:35AM | Business Wire | ARIAD and Paladin Announce Commercial Distribution Agreement for Iclusig (Ponatinib) in Canada | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 06/10/2015 | 7:35AM | Business Wire | ARIAD Et Laboratoires Paladin Annoncent La Signature D’une Entente De Distribution Commerciale D’iclusig (Ponatinib) Au C... | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 06/08/2015 | 7:35AM | Business Wire | ARIAD to Present at the Goldman Sachs Annual Global Healthcare Conference | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 06/01/2015 | 9:00AM | Business Wire | ARIAD Presents Updated Clinical Data on brigatinib in Patients with ALK+ Non-Small Cell Lung Cancer at the 2015 ASCO Meeting | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 05/31/2015 | 9:00AM | Business Wire | ARIAD Announces Long-Term Safety & Efficacy Data Of Ponatinib in Chronic-Phase Chronic Myeloid Leukemia from Phase 1 Clinical... | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 05/22/2015 | 10:59AM | Business Wire | ARIAD meldet Datenpräsentationen auf dem Kongress der Europäischen Gesellschaft für Hämatologie (EHA) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 05/22/2015 | 7:35AM | Business Wire | ARIAD Announces Data Presentations at the European Hematology Association (EHA) Congress | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 05/21/2015 | 7:35AM | Business Wire | ARIAD to Present at the Jefferies 2015 Global Healthcare Conference | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 05/14/2015 | 7:35AM | Business Wire | ARIAD Announces Data Presentations at the 2015 ASCO Annual Meeting | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 05/08/2015 | 5:36PM | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 05/07/2015 | 7:46AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 05/07/2015 | 7:35AM | Business Wire | ARIAD Reports First Quarter 2015 Financial Results and Progress on Strategic Objectives | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 05/06/2015 | 7:35AM | Business Wire | ARIAD Announces Commercial Distribution Agreement for Iclusig (ponatinib) in Turkey | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 05/05/2015 | 8:12PM | Analyst Ratings Network | Ariad Pharmaceuticals Upgraded by Vetr Inc. to Buy (ARIA) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 05/05/2015 | 8:11AM | The Motley Fool | Is This Why the Street Keeps Doubting Gilead Sciences, Inc.? | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 05/04/2015 | 8:10PM | Analyst Ratings Network | Vetr Inc. Lowers Ariad Pharmaceuticals to Hold (ARIA) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 05/04/2015 | 4:38PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |